Tech Mahindra Named a Leader in Everest Group PEAK Matrix Assessment for Software Product Engineering Services 2021
26.8.2021 12:00:00 EEST | Business Wire | Press release
Tech Mahindra, a leading provider of digital transformation, consulting and business re-engineering services, announced that it has been named a leader in Everest Group PEAK Matrix Assessment for Software Product Engineering Services 2021. The recognition reiterates Tech Mahindra’s Integrated Engineering Solutions (IES) leadership in delivering solutions enabling “Digital Engineering Enterprise” across verticals.
Tech Mahindra was evaluated for its engineering services across domains, including Aerospace and Defense, Automotive, Industrial, Telecom, Healthcare, Energy & Utilities and ISVs. With 50+ global engineering centers supporting new program launches and over 350 active global customers, Tech Mahindra is an established leader for Engineering Services in the industry.
L. Ravichandran, President and Chief Operating Officer, Tech Mahindra, said, “With accelerated digitalization across industries, the world of engineering has dynamically transformed, leading to innovation in software engineering, adoption of disruptive technologies, thus bringing in excellence into core engineering and smarter operations. As part of our TechM NXT.NOW framework, we are offering extensive engineering solutions, including products, software and technologies to build capabilities and enhance competencies through strategic collaborations. The recognition is a testimony to our continued investments in becoming a full stack service provider in engineering space with capabilities across research and development product engineering, design, consulting, manufacturing services, software development & aftermarket.”
Tech Mahindra offers a blend of talent, technology, business acumen, and domain expertise to collaborate with enterprises on their engineering journey – helping them accelerate positive outcomes from existing engineering initiatives and investments, invent new products and IP (Internet Protocol), and transform business models in alignment with the dynamic market requirements, while traversing towards a sustainable future.
“Tech Mahindra drives differentiation in the software product engineering market through co-innovation initiatives with its customers and joint GTM programs with digital majors such as Cisco and Microsoft. The company derives over half of its software product engineering business from ISVs and internet companies and is also strategically focused on deepening its play with large enterprise customers. While on one hand, the company has showcased an appetite for product carve outs and IP partnerships-based models, it has also been open to value-based pricing, something customers have come to appreciate. Customers also value Tech Mahindra’s commercial competitiveness, project management capabilities, and high flexibility during service delivery,” said Akshat Vaid, Vice President, Everest Group.
The Everest Group report focuses on engineering services related to the development, testing and maintenance of software products, such as commercial off-the-shelf products for enterprises or customer-facing software/portals/applications meant for revenue generation or service delivery. The report assessed 31 service providers for capabilities on software engineering services based on their market success and delivery capability.
As part of TechM NXT.NOW framework, which aims to enhance ‘Human Centric Experience’, Tech Mahindra focuses on investing in emerging technologies and solutions that enable digital transformation and meet the evolving needs of the customer.
Connect with us on www.techmahindra.com
Our Social Media Channels
Facebook: https://www.facebook.com/TechMahindra
Twitter: https://twitter.com/Tech_Mahindra
LinkedIn: https://www.linkedin.com/company/tech-mahindra/
YouTube: https://www.youtube.com/user/techmahindra09
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210826005278/en/
Contact information
Abhilasha Gupta, Global Corporate Communications and Public Affairs
Email: Abhilasha.Gupta@TechMahindra.com; media.relations@techmahindra.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 05:00:00 EEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 02:51:00 EEST | Press release
Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equity among HCPs, patients, regulators and other stakeholders. A global leader in women’s health, the company’s portfolio includes more than 70 products across Women’s Health and General Medicines, which includes biosimila
PMC Organometallix Announces Price Increase on All Products25.4.2026 00:02:00 EEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi ® arbitral award in favor of AOP Health24.4.2026 19:52:00 EEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 17:37:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be entitled to benefits including enhanced communications and a shortened 1-2 month review time following filing of a New Drug Application (NDA), while maintaining FDA’s rigorous safety and efficacy standards. “We are honored and grateful to be selected for the CNPV which is a clear validation of both the urgent unmet need facing millions of people living with treatment resistant depression and the innovative science of COMP360,” said Kabir Nath, Chief Executive Officer of Compass Pathways. “As the most advan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom